IRON
Disc Medicine Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.55B
P/E Ratio
—
EPS
$-6.64
Beta
2.14
52W High
$99.50
52W Low
$40.00
50-Day MA
$65.93
200-Day MA
$72.28
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Disc Medicine Inc.
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company is headquartered in Watertown, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-264.40M |
| Operating Margin | 0.00% |
| Return on Equity | -35.80% |
| Return on Assets | -22.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $18.03 |
| Price-to-Book | 3.71 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -7.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $38.20M |
| Float | $32.75M |
| % Insiders | 7.78% |
| % Institutions | 113.56% |
Historical Volatility
HV 10-Day
42.15%
HV 20-Day
33.03%
HV 30-Day
33.61%
HV 60-Day
38.60%
HV Rank
26.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($101.09 target)
1
Strong Buy12
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026